— Know what they know.
Not Investment Advice

DNAG OTC

DNAPrint Genomics, Inc.
1W: +0.0% 1M: +0.0% 3M: +0.0% YTD: +100.0% 1Y: +100.0% 3Y: -80.0% 5Y: +100.0%
$0.00
+0.00 (+0.00%)
 
OTC · Healthcare · Biotechnology · Tech Score Neutral · Power 50 · $12892 mcap · 413M float · 0.079% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market Cap$0.0M
52W Range0.000001-0.0001
Volume331,500
Avg Volume324,888
Beta1.53
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEOJatin Patel
Employees24
SectorHealthcare
IndustryBiotechnology
IPO Date2001-02-22
1621 West University Parkway
Sarasota, FL 34243
US
About DNAPrint Genomics, Inc.

DNAPrint Genomics, Inc. focuses on pioneering and distributing genetic analysis solutions and services. Their product portfolio includes AncestryByDNA, a comprehensive chromosomal assay for tracing genetic lineage, and EurasianDNA, designed to identify specific European ancestral subdivisions. They also offer EuropeanDNA, which outlines an individual's fundamental continental European heritage. In forensic science, DNAWitness assists in determining genetic background from crime scene samples, while RETINOME is utilized by detectives to construct physical traits, such as eye color, from DNA evidence or human remains. Furthermore, the company provides the GenomeLab SNPstream Genotyping System, recognized for its high genotyping throughput, multiplexing capabilities, and efficient reagent usage. DNAPrint Genomics caters to diverse clients in fields like forensic investigation, genealogical exploration, consumer products, and pharmaceutical research. Originally incorporated in 1983 as Lexington Energy, Inc., the company operates from Sarasota, Florida, with an international presence through a subsidiary in Leverkusen, Germany.

Latest News
No recent news

Recent Insider Trades

NameTypeSharesPriceDate
GABRIEL RICHARD L A-Award 20,000,000 $0.01 2007-04-27

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms